APOE and Alzheimer disease: To evaluate the potential functional consequences of high-risk ApoE mutations in the context of AD, molecular docking was employed to assess the interaction between the wild-type (WT) and mutant ApoE proteins (L122P and L107P) with amyloid-beta (Aβ) peptides.